| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $10,040,038 | 10 | 77 |
Sells | $18,068,561 | 3 | 23 |
| Mahoney Michael F | Chairman, President & CEO | 1 | $9M | 1 | $15.04M | $-6.04M |
| LUDWIG EDWARD J | director | 2 | $430,314 | 0 | $0 | $430,314 |
| Habiger David C | director | 5 | $407,922 | 0 | $0 | $407,922 |
| Morano Susan E | director | 1 | $100,408 | 0 | $0 | $100,408 |
| Pegus Cheryl | director | 1 | $99,987 | 0 | $0 | $99,987 |
| Zane Ellen M | director | 0 | $0 | 1 | $1.27M | $-1.27M |
| Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | 0 | $0 | 1 | $1.76M | $-1.76M |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | 0 | $0 | 1 | $4.97M | $-4.97M |
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological …
Over the last 12 months, insiders at Boston Scientific Corporation have bought $10.04M and sold $18.07M worth of Boston Scientific Corporation stock.
On average, over the past 5 years, insiders at Boston Scientific Corporation have bought $4.05M and sold $64.8M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mahoney Michael F (Chairman, President & CEO) — $9M. LUDWIG EDWARD J (director) — $430,314. Habiger David C (director) — $407,922.
The last purchase of 2,040 shares for transaction amount of $100,408 was made by Morano Susan E (director) on 2026‑08‑25.
| 2026-08-25 | Morano Susan E | director | 2,040 0.0001% | $49.22 | $100,408 | -11.53% | ||
| 2026-08-05 | Habiger David C | director | 2,100 0.0001% | $47.59 | $99,937 | -5.91% | ||
| 2026-08-04 | Habiger David C | director | 140 <0.0001% | $48.59 | $6,802 | -8.45% | ||
| 2026-08-03 | Mahoney Michael F | Chairman, President & CEO | 186,240 0.0126% | $48.33 | $9M | -7.17% | ||
| 2026-08-03 | Habiger David C | director | 1,042 <0.0001% | $48.07 | $50,084 | -7.17% | ||
| 2026-07-31 | LUDWIG EDWARD J | director | 5,000 0.0003% | $45.48 | $227,400 | -3.77% | ||
| 2026-05-20 | LUDWIG EDWARD J | director | 3,580 0.0002% | $56.68 | $202,914 | -20.50% | ||
| 2026-05-20 | Habiger David C | director | 2,250 0.0001% | $55.92 | $125,819 | -20.50% | ||
| 2026-05-20 | Pegus Cheryl | director | 1,770 0.0001% | $56.49 | $99,987 | -20.50% | ||
| 2026-05-19 | Habiger David C | director | 2,200 0.0001% | $56.95 | $125,279 | -20.69% | ||
| 2026-02-02 | Sale | Mahoney Michael F | Chairman, President & CEO | 160,901 0.011% | $93.49 | $15.04M | -46.68% | |
| 2025-12-01 | Sale | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | 17,313 0.0012% | $101.55 | $1.76M | -46.80% | |
| 2025-11-06 | Sale | Zane Ellen M | director | 12,891 0.0008% | $98.28 | $1.27M | -42.72% | |
| 2025-11-03 | Sale | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | 50,000 0.0033% | $99.47 | $4.97M | -42.34% | |
| 2025-10-28 | Sale | Zane Ellen M | director | 2,901 0.0002% | $102.24 | $296,599 | -42.91% | |
| 2025-10-27 | Sale | Zane Ellen M | director | 9,990 0.0007% | $101.13 | $1.01M | -43.59% | |
| 2025-10-01 | Sale | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | 50,000 0.0034% | $98.47 | $4.92M | -32.99% | |
| 2025-09-02 | Sale | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | 50,000 0.0033% | $105.43 | $5.27M | -31.93% | |
| 2025-08-01 | Sale | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | 50,000 0.0034% | $104.63 | $5.23M | -14.04% | |
| 2025-08-01 | Sale | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | 17,313 0.0012% | $104.63 | $1.81M | -14.04% |
| Mahoney Michael F | Chairman, President & CEO | 1590024 0.1097% | $69.17M | 3 | 29 | +37.05% |
| LUDWIG EDWARD J | director | 30359 0.0021% | $1.32M | 3 | 6 | +26.95% |
| Habiger David C | director | 17160 0.0012% | $746,460.00 | 5 | 0 | |
| Morano Susan E | director | 13784 0.001% | $599,604.00 | 1 | 0 | |
| Pegus Cheryl | director | 1770 0.0001% | $76,995.00 | 1 | 0 | |
| ABELE JOHN E | Director Emeritus | 500000 0.0345% | $21.75M | 5 | 212 | +7.41% |
| BEST LAWRENCE C | EVP | 232189 0.016% | $10.1M | 1 | 24 | <0.0001% |
| NICHOLAS NJ JR | director | 225000 0.0155% | $9.79M | 20 | 1 | +2.99% |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | 178342 0.0123% | $7.76M | 1 | 26 | +12.4% |
| ELLIOTT JOHN RAYMOND | director | 118264 0.0082% | $5.14M | 1 | 0 | <0.0001% |
| Kucheman William | Chief Executive Officer | 112525 0.0078% | $4.89M | 3 | 1 | +27.04% |
| MARIO ERNEST | director | 86032 0.0059% | $3.74M | 22 | 18 | +4.51% |
| PEPPER JOHN E | director | 58807 0.0041% | $2.56M | 3 | 0 | <0.0001% |
| Sununu John E | director | 32265 0.0022% | $1.4M | 3 | 4 | +4.31% |
| Bartlett Katharine T | director | 29708 0.002% | $1.29M | 1 | 0 | +4.24% |
| Connors Nelda J | director | 27246 0.0019% | $1.19M | 1 | 4 | <0.0001% |
| WICHMANN DAVID S | director | 25000 0.0017% | $1.09M | 1 | 0 | +0.3% |
| FLEISHMAN JOEL LAWRENCE | director | 18250 0.0013% | $793,875.00 | 1 | 0 | +1.14% |
| BURNS URSULA M | director | 13500 0.0009% | $587,250.00 | 4 | 0 | <0.0001% |
| MORECI STEPHEN F | SVP, Global Sales Operations | 7216 0.0005% | $313,896.00 | 1 | 7 | <0.0001% |
| REINHARDT UWE E | director | 5000 0.0003% | $217,500.00 | 3 | 1 | <0.0001% |
| Goodman Jeffrey H | SVP, International | 5000 0.0003% | $217,500.00 | 2 | 0 | <0.0001% |
| FOX MARYE ANNE | director | 3305 0.0002% | $143,767.50 | 1 | 0 | +18.63% |
| GROVES RAY J | director | 1000 0.0001% | $43,500.00 | 3 | 0 | <0.0001% |
| Dockendorff Charles J | director | 0 0% | $0 | 1 | 2 | +35.4% |
| Increased Positions | 919 | +49.04% | 110M | +8.09% |
| Decreased Positions | 836 | -44.61% | 95M | -7.01% |
| New Positions | 219 | New | 25M | New |
| Sold Out Positions | 137 | Sold Out | 6M | Sold Out |
| Total Postitions | 1,957 | +4.43% | 1B | +1.08% |
| Blackrock, Inc. | $13.75M | 9.8% | 145.18M | -2M | -1.03% | 2025-09-30 |
| Vanguard Group Inc | $13.09M | 9.33% | 138.25M | +1M | +0.81% | 2025-09-30 |
| Fmr Llc | $9.42M | 6.71% | 99.48M | -9M | -8.15% | 2025-09-30 |
| State Street Corp | $6.15M | 4.38% | 64.93M | -266,300 | -0.41% | 2025-09-30 |
| Bank Of America Corp /De/ | $3.21M | 2.29% | 33.87M | +23,922 | +0.07% | 2025-09-30 |
| Primecap Management Co/Ca/ | $3.14M | 2.23% | 33.1M | -2M | -4.5% | 2025-09-30 |
| Geode Capital Management, Llc | $3.1M | 2.21% | 32.69M | +265,546 | +0.82% | 2025-09-30 |
| Jpmorgan Chase & Co | $2.68M | 1.91% | 28.33M | +3M | +10.4% | 2025-09-30 |
| Capital World Investors | $2.52M | 1.8% | 26.65M | -2M | -6.58% | 2025-09-30 |
| Morgan Stanley | $1.96M | 1.4% | 20.71M | +450,584 | +2.22% | 2025-09-30 |